Max Healthcare Institute disclosed on July 24, 2026, that the National Company Law Tribunal (NCLT), Cuttack Bench, has adjourned the hearing on petitions filed by BRS Capital Two Pte. Limited against its subsidiary, Kalinga Hospital Ltd. The tribunal listed the matter on July 23, 2026, at 2:30 pm IST and subsequently deferred the next hearing to August 4, 2026. This development follows earlier intimations by the company dated May 19, 2026, and July 8, 2026, regarding the legal proceedings initiated by the legal representatives of BRS Capital Two Pte. Limited.

Legal Proceedings Status

The petitions involve Kalinga Hospital Ltd., a subsidiary of Max Healthcare Institute, as well as the company itself and the other shareholder from whom Max Healthcare acquired the majority equity stake in Kalinga Hospital. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that no settlement has been reached and provides no further details on the specific nature or grounds of the petitions beyond their listing before the tribunal.

Regulatory Disclosure

The company stated that this disclosure continues its previous notifications regarding the ongoing litigation. The details were submitted to both the National Stock Exchange of India Limited and BSE Limited. The filing does not indicate any immediate financial impact or change in the status of the proceedings other than the procedural adjournment. Stakeholders are advised to monitor the outcome of the hearing scheduled for August 4, 2026, for any material developments in the case.

Max Healthcare Institute Ltd will host a group investor meeting in Delhi on July 14, 2026, to engage with shareholders and analysts. The physical meeting is organized by Kotak Securities Limited and aims to provide insights into the company's operations and future outlook.

The event is scheduled under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dhiraj Aroraa, Executive Vice President - Company Secretary and Compliance Officer, filed the disclosure with the exchanges.

Meeting Details

The following table outlines the key particulars of the scheduled investor conference:

This initiative allows investors to interact directly with the management of max healthcare institute and understand the strategic direction of the healthcare provider.